Ovarian follicular dynamics: From basic science to clinical practice

Journal of Reproductive Immunology

Volumn 39, Issue 1-2, 1998, Pages 29-61

  Pellicer, Antonio ^a,b   Gaitán, Pilar ^a   Neuspiller, Fernando ^a   Ardiles, Gerardo ^a   Albert, Carmela ^a   Remohí, José ^a   Simón, Carlos ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Angiogenesis; Controled ovarian hyperstimulation; Low responders; Oocyte donation; Ovarian aging; Ovarian follicles; Ovarian reserve

Indexed keywords

CYTOKINE; GONADOTROPIN; GROWTH FACTOR; GROWTH HORMONE;

BIRTH RATE; CLINICAL PRACTICE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONFERENCE PAPER; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENETIC ENGINEERING; GRANULOSA CELL; HUMAN; OOCYTE; ORGAN DONOR; OVARY FOLLICLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGING; ANIMALS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMANS; OVARIAN FOLLICLE; OVULATION INDUCTION;

EID: 0032143316     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(98)00012-6     Document Type: Conference Paper

References (110)

1. Adashi E.Y. Intraovarian peptides: stimulators and inhibitors of follicular growth and differentiation. Reprod. Endocrinol. 21:1992;1-17.
2. Adashi E.Y. The potential relevance of cytokines to ovarian physiology. J. Steroid Biochem. Mol. Biol. 43:1992;439-444.
3. Anderson W.F. Human gene therapy. Science. 256:1992;808-813.
4. Baker T.G. A quantitative and cytological study of germ cells in human ovaries. Proc. R. Soc. London B Biol. Sci. 158:1963;417-433.
5. Balasch J., Creus M., Fábregues F., Carmona F., Casamitjana R., Ascaso C., Vanrell J.A. Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Am. J. Obstet. Gynecol. 175:1996;1226-1230.
6. Battaglia D.E., Goodwin P., Klein N.A., Soules M.R. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum. Reprod. 11:1996;2217-2222.
7. Ben-Rafael Z, Lipitz S., Rider D., Mashiach S. Ovarian hyporesponsiveness in combined gonadotropin -releasing hormone- agonist and menotropin therapy is associated with low semm follicle stimulating hormone levels. Fertil. Steril. 55:1991;272-275.
8. Bergh C., Hillensjö T., Wikland M., Nilsson L., Borg G., Hamberger L. Adjuvant growth hormone treatment during in vitro fertilization: a randomized placebo controlled study. Fertil. Steril. 62:1994;113-120.
9. Block E. A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anat. (Basel). 17:1953;201-206.
10. Blumenfeld Z. Growth hormone - a cogonadotropin? Its role in ovulation induction. J. In Vitro Fertil. Embryo Transfer. 8:1991;127-136.
11. Buckler H.M., Evans C.A., Mamtora H., Burger H.G., Anderson D.C. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles. J. Clin. Endocrinol. Metab. 72:1991;116-124.
12. Cameron I.T., O'Shea F.C., Rolland J.M., Hughes E.G., de Kretser D.M., Healy D.L. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J. Clin. Endocrinol. Metab. 67:1988;1190-1194.
13. Cano F., Simón C., Remohí J., Pellicer A. Effect of aging on the female reproductive system: evidence for a role of uterine senescence in the decline in female fecundity. Fertil. Steril. 64:1995;584-589.
14. Conaghan J., Hardy K., Handyside A.H., Winston R.M.L., Leese H.J. Selection criteria for human embryo transfer: a comparison of pyruvate uptake and morphology. J. Assisted Reprod. Genet. 10:1993;21-30.
15. Conte F.A., Grumbach M.M., Ito Y., Fisher C.R., Simpson E.R. A syndrome of female pseudohermaphroditism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J. Clin. Endocrinol. Metab. 78:1994;1287-1292.
16. Chandrasekher Y.A., van Dessel H.J.H.M., Fauser B.C.J.M., Giudice L.C. Estrogen - but not androgen dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease. J. Clin. Endocrinol. Metab. 80:1995;2734-2739.
17. Danforth D.R., Cheng C.Y. Purification of a candidate gonadotropin surge inhibiting factor from porcine follicular fluid. Endocrinologv. 136(4):1995;1658-1665.
18. Dor J., Ben-Shlomo I., Lunenfeld B., Pariente C., Levran D., Karasik A., Seppala M., Mashiach S. Insulin-like growth factor-I (IGF-I) may not be essential for ovarian follicular development: evidence from IGF-I deficiency. J. Clin. Endocrinol. Metab. 74:1992;539-542.
19. el-Roeiy A., Chen X., Roberts V.J. Jr., LeRoith D., Roberts C.T., Yen S.S.C. Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. J. Clin. Endocrinol. Metab. 77:1993;1411-1418.
20. el-Roeiy A., Chen X., Roberts V.J. Jr., Shimasaki O., Ling N., LeRoith D., Roberts C.T., Yen S.S.C. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1 6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. J. Clin. Endocrinol. Metab. 78:1994;1488-1496.
21. Erickson G.F., Danforth D.R. Ovarian control of follicle development. Am. J. Obstet. Gynecol. 172:1995;736-747.
22. Fábregues F., Peñarrubia J., Creus M., Moreno V., Cívico S., Puerto B., Balasch J., Vanrell J.A. Características del desarrolo folicular y resultados de la fecundación in vitro en ciclo no estimulado en pacientes con FSH basal elevada. Prog. Obstet. Gin. 40:1997;194-198.
23. Faddy M.J., Gosden R.G. A mathematical model of follicle dynamics in the human ovary. Hum. Reprod. 10:1995;770-775.
24. Faddy M.J., Gosden R.G., Gougeon A., Richardson S.J., Nelson J.F. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum. Reprod. 7:1992;1342-1346.
25. Fanchin R., de Ziegler D., Olivennes F., Taieb J., Dzik A., Frydman R. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting 'poor responders' in in vitro fertilization. Hum. Reprod. 91:1994;1607-1611.
26. Fares F.A., Suganuma N., Nishimori K., La Poll P.S., Hsueh A.J.W., Boime I. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc. Natl. Acad. Sci. USA. 89:1992;4304-4308.
27. Farhi J., Homburg R., Ferber A., Orvieto R., Ben Rafael Z. Non-response to ovarian stimulation in normogonadotropic, normogonadal women: a clinical sign of impending onset of ovarian failure pre-empting the rise in basal follicle stimulating hormone levels. Hum. Reprod. 12:1997;241-243.
28. Fauser B.C.J.M. Interference with follicle-stimulating hormone regulation of human ovarian function. Mol. Hum. Reprod. 2:1996;327-334.
29. Fauser B.C.J.M., Van Heusden A.M. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr. Rev. 18:1997;71-106.
30. Feldberg D., Farhi J., Ashlkenazi J., Dicker D., Shalev J., Ben-Rafael Z. Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil. Steril. 62:1994;343-346.
31. Flood J.T., Chillik C.F., van Uem J.F.H.M., Iritani A., Hodgen G.D. Ooplasmic transfusion: prophase germinal vesicle oocytes made developmentally competent by microinjection of metaphase-II egg cytoplasm. Fertil. Steril. 53:1990;1049-1056.
32. Forabosco A., Sforza C., de Pol A., Vizzotto L., Marzona L., Ferrario V. Morphometric study of the human neonatal ovary. Anal. Rec. 231:1991;201-208.
33. Furuhashi M., Shikone T., Fares F.A., Sugahara T., Hsueh A.J.W., Boime I. Fusing the carboxy-terminal peptide of the chorionic gonadotropin (CG) beta-subunit to the common alpha subunit retention of 0-linked glycosylation and enhanced in vivo bioactivity of chimeric human CG. Mol. Endocrinol. 9:1995;54-63.
34. Garcia, J.E., Baramki, T., Padilla, S.L., et. al., 1992. Growth hormone as an adjunct to ovulation induction in in vitro fertilization, a last resort for refractory responders. In: Abstracts of the 48th Annual Meeting of the American Fertility Society, p. 20.
35. Gast M. Evolution of clinical agents for ovulation induction. Am. J. Obstet. Gynecol. 172:1995;753-765.
36. Gast M. The evolution of new agents for ovulation induction. Sem. Reprod. Endocrinol. 14:1996;375-389.
37. Giudice L.C. Insulin-like growth factors and ovarian follicular development. Endocr. Rev. 13:1992;641-669.
38. Giudice L.C., Saleh W. Growth factors in reproduction. Trends Endocrinol. Metab. 6:1995;60-69.
39. Gougeon A., Ecochard R., Thalabard J.C. Age-related changes of the population of human ovarian follicles: increase in the disappearance rate of non-growing and early-growing follicles in aging women. Biol. Reprod. 50:1994;653-663.
40. Guanes P.P., Remohí J., Gallardo E., Valbuena D., Simón C., Pellicer A. Age does not affect uterine resistance to vascular flow in patients undergoing oocyte donation. Fertil. Steril. 66:1996;265-270.
41. Halvorson L., De Cherney A. Inhibin, activin, and follistatin in reproductive medicine. Fertil. Steril. 65:1996;459-467.
42. Hillard M.A., Wilkins J.P., Cummins L.J., Bindon B.M., Tsonis C.G., Findlay J.K., Oshea T. Immunological manipulation of ovulation rate for twinning in cattle. J. Reprod. Fertil. 49:1995;351-364.
43. Hofmann G.E., Danforth D., Seifer D.B. Inhibin B: the physiologic basis of the clomiphene citrate challenge test for ovarian reserve screening. J. Soc. Gynecol. Invest. 4:1997;122A.
44. Hsu S.Y., Kubo M., Chun S.Y., Haluska F.G., Housman D.E., Hsueh A.J.W. Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter. Mol. Endocrinol. 9:1995;1356-1366.
45. Hughes E.G., Robertson D.M., Handelsman D.J., Hayward S., Healy D.L., de Kretser D.M. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome. J. Clin. Endocrinol. Metab. 70:1990;358-364.
46. Ibrahim Z.H., Matson P.L., Buck P., Lieberman B. The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response. Fertil. Steril. 55:1991;202-204.
47. Jacobs S.L., Metzger D.A., Dodson W.C., Haney A.F. Effect of age on response to human menopausal gonadotropin stimulation. J. Clin. Endocrinol. Metab. 71:1990;1525-1530.
48. Janny L., Menezo Y.J.R. Maternal age effect on early human embryonic development and blastocyst formation. Mol. Reprod. Dev. 45:1996;31-37.
49. Karande V.C., Jones G.S., Veeck L.L., Muasher S.J. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertil. Steril. 53:1990;486-489.
50. Keefe D.L., Niven-Fairchild T., Powell G., Buradagunta S. Mitochondrial deoxyribonucleic acid deletion in oocytes and reproductive aging in women. Fertil. Steril. 64:1995;577-583.
51. Klein N.A., Illingworth P.J., Groome N.P., McNeilly A.S., Battaglia D.E., Soules M.R. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J. Clin. Endocrinol. Metab. 81:1996;2742-2745.
52. Klein N.A., Battaglia D.E., Fujimoto V.Y., Davis G.S., Bremner W.J., Soules M.R. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J. Clin. Endocrinol. Metab. 81:1996;1038-1045.
53. Land J.A., Yarmolinskaya M.I., Domoulin J.C.M., Evers J.L.H. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil. Steril. 65:1996;961-965.
54. Latronico A.C., Anasti J., Amhold I.J., Rapaport R., Mendonca B.B., Bloise W., Castro M., Tsigos C., Chrousos G.P. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. New Engl. J. Med. 334:1996;507-512.
55. Lee D.W., Grasso P., Dattatreyamurty B., Deziel M.R., Reichert L.E. Jr. Purification of a high molecular weight follicle-stimulating hormone receptor-binding inhibitor from human follicular fluid. J. Clin. Endocrinol. Metab. 77:1993;160-168.
56. Lenton E.A., de Kretser D.M., Woodward A.J., Robertson D.M. Inhibin concentrations throughout the menstrual cycles of normal, infertile, and older women compared with those during spontaneous conception cycles. J. Clin. Endocrinol. Metab. 73:1991;1180-1190.
57. Levron J., Lewit N., Erlik Y. No beneficial effects of human growth hormone therapy in normal ovulatory patients with a poor ovarian response to gonadotropins. Gynecol. Obstet. Invest. 35:1993;65-68.
58. Levy T., Limor R., Villa Y., Eshel A., Eckstein N., Vagman I., Lidor A., Ayalon D. Another look at co-treatment with growth hormone and human menopausal gonadotropins in poor ovarian responders. Hum. Reprod. 8:1993;834-839.
59. Lindheim S.R., Vidali A., Ditkoff E., Sauer M.V., Zinger M. Poor responders to ovarian hyperstimulation may benefit from an attempt at natural-cycle oocyte retrieval. J. Assisted Reprod. Genet. 14:1997;174-179.
60. Ling N., Ui M., Shimonaka M., Shimasaki S., Bicsak T.A. An ICF-binding protein in ovarian follicular fluid blocks FSH-stimulated steroid production by ovarian granulosa cells. Yen S.S.C., Vale W.W. Neuroendocrine Regulation of Reproduction. 1990;207-215 Serono Symposia Series, Norwell.
61. Loumaye E., Billion J.M., Mine J.M., Psalit I., Pensis M., Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil. Steril. 53:1990;295-301.
62. Manzi D.L., Thornton K.L., Scott L.B., Nulsen J.C. The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response. Fertil. Steril. 62:1994;343-346.
63. Menken J., Trussell J., Larsen U. Age and infertility. Science. 233:1986;1389-1394.
64. Miller P.B., Charleston J.S., Battaglia D.E., Klein N.A., Soules M.R. An accurate, simple method for unbiased determination of primordial follicle number in the primate ovary. Biol. Reprod. 56:1997;909-915.
65. Morishima A., Grumbach M.M., Simpson E.R., Fisher C., Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80:1995;3689-3698.
66. Mukherjee T., Copperman A.B., Lapinski R., Sandler B., Bustillo M., Grunfeld L. An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil. Steril. 65:1996;588-593.
67. Mulligan R.C. The basic science of gene therapy. Science. 261:1993;926-932.
68. Munné S., Alikani M., Tomkin G., Grifo J., Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosomal abnormalities. Fertil. Steril. 64:1995;382-391.
69. Navot D., Rosenwaks Z., Margalioth E.J. Prognostic assessment of female fecundity. Lancet. 2:1987;645-647.
70. Owen E.J., Shoham Z., Mason B.A., Ostergaard H., Jacobs H. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil. Steril. 56:1991;1104-1110.
71. Owen E.J., West C., Mason B.A., Jacobs H. Cotreatment with growth hormone of suboptimal responders in IV-ET. Hum. Reprod. 6:1991;524-528.
72. Pellicer, A., 1997. Estrogens and follicular and oocyte development. Hum. Reprod. Update 3 (in press).
73. Pellicer A., Lightman A., Diamond M.P., Russell J.B., De Cherney A.H. Outcome of in vitro fertilisation in women with low response to ovarian stimulation. Fertil. Steril. 47:1987;812-815.
74. Pellicer A., Simón C., Miró F., Castellví R.M., Ruiz A., Ruiz M., Pérez M., Bonilla-Musoles F. Ovarian response and outcome of in vitro fertilization in patients treated with gonadotropin-releasing hormone analogues in different phases of the menstrual cycle. Hum. Reprod. 4:1989;285-289.
75. Pellicer A., Gomez E., de los Santos M.J., Remohi J. Growth hormones and factors in assisted reproduction. Assisted Reprod. Rev. 2:1992;134-147.
76. Pellicer A., Ballester M.J., Serrano M.D., Mir A., Serra-Serra V., Remohí J., Bonilla-Musoles F. Aetiologic factors involved in the low response to gonadotropins in infertile women with normal basal serum follicle stimulating hormone. Hum. Reprod. 9:1994;806-811.
77. Pellicer A., Marí M., De los Santos M.J., Simón C., Remohí J., Tarín J.J. Effects of aging on the human ovary: the secretion of immunoreactive α-inhibin and progesterone. Fertil. Steril. 61:1994;663-668.
78. Plachot M., Veiga A., Montagut J., de Grouchy J., Calderón G., Lepretre S., Junca A.M., Santaló J., Carles E., Mandelbaum J., Barri P., Degoy J., Cohen J., Egozcue J., Sabatier J.C., Salat-Baroux J. Are clinical and biological IVF parameters correlated with chromosomal disorders in early life: a multicentric study. Hum. Reprod. 3:1988;627-635.
79. Popkin R.M., Bramley T.A., Currie A.J., Shaw R.W., Baird D.T., Fraser H.M. Specific binding of luteinizing hormone releasing hormone to human tissue. Biochem. Biophys. Res. Commun. 114:1983;750-756.
80. Rabinovici J., Cataldo N.A., Dandekar P., Rosenthal S.M., Gargosky S.E., Gesundheit N., Martin M.C. Adjunctive growth hormone during ovarian hyperstimulation increases levels of insulin-like growth factor binding proteins in follicular fluid: a randomized, placebo-controlled, cross-over study. J. Clin. Endocrinol. Metab. 82:1997;1171-1176.
81. Reissmann T., Felberbaum R., Diedrich K., Engel J., Comar-uschally A.M., Schally A.V. Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview. Hum. Reprod. 10:1995;1974-1981.
82. Remohí J, Gutierrez A, Cano F, Ruiz A, Simón C, Pellicer A. Long oestradiol replacement in an oocyte donation programme. Hum. Reprod. 10:1995;1387-1391.
83. Remohí J., Gartner B., Gallardo E., Yalil S., Simón C., Pellicer A. Pregnancy and birth rates after oocyte donation. Fertil. Steril. 67:1997;717-723.
84. Richard T., Scott M.D. Jr. Evaluation and treatment of low responders. Semin. Reprod. Endocrinol. 14:1996;317-337.
85. Roest J., van Heusden A.M., Mous H., Zeilmaker G.H., Verhoeff A. The ovarian response as a predictor for successful in vitro fertilization treatment after the age of 40 years. Fertil. Steril. 66:1996;969-973.
86. Rosenwaks, Z., Davis, O.K., 1993. Implantation efficiency and egg donation in women with elevated FSH concentrations and advanced chronological age. In: Proceedings of the Eighth Reinier de Graaf Symposium, pp. 49-55.
87. Sanzo M.A., Reichert L.E. Gonadotropin receptor binding regulators in serum. J. Biol. Chem. 257:1982;6033-6041.
88. Scott R.T., Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil. Steril. 61:1994;880-885.
89. Scott R.T., Leonardi M.R., Hofmann G.E., Illions E.H., Neat G.S., Navot D. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet. Gynecol. 82:1993;53-545.
90. Schneyer A.L., Sluss P.M., Whitcomb R.W., Martin K.A., Sprengel R., Crowley W.F. Precursors of α-inhibin modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology. 129:1991;1987-1999.
91. Schoolcraft W., Schlenker T., Gee M., Stevens J., Wagley L. Improved controlled ovarian hyperstimulation in poor responder in in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil. Steril. 67:1997;93-97.
92. Seifer D.B., Gardiner A.C., Ferreira K.A., Peluso J.J. Apoptosis as a function of ovarian reserve in women undergoing in vitro fertilization. Fertil. Steril. 66:1996;593-598.
93. Seifer D.B., Gardiner A.C., Lambert-Messerlian G., Schneyer A.L. Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J. Clin. Endocrinol. Metab. 81:1996;736-739.
94. Seifer D.B., Lambert-Messerlian G., Hogan J.W., Gardiner A.C., Blazar A.S., Berk C.A. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil. Steril. 67:1997;110-114.
95. Shaker A.G., Fleming R., Jamieson M.E. et al. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotropins in women: normal and poor responders. Fertil. Steril. 58:1992;919-923.
96. Sheehan K.L., Casper R.E., Yen S.S.C. Induction of luteolysis by luteinising hormone releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility. Fertil. Steril. 37:1982;209-212.
97. Sugahara T., Pixley M.R., Minami S., Perlas E., Benmenahem D., Hsueh A.J.W. Biosynthesis of a biologically active single peptide chain containing the human common alpha and chorionic gonadotropin beta subunits in tandem. Proc. Natl. Acad. Sci. USA. 92:1995;2041-2045.
98. Tesarik J., Mendoza C. Nongenomic effects of 17β-estradiol on maturing human oocytes: relationship to oocyte developmental potential. J. Clin. Endocrinol. Metab. 80:1995;1438-1443.
99. Toledo S.P., Brunner H.G., Kraaij R., Dahia P.M., Hayashida C.Y., Kremer H., Themmen A.P. An inactivating mutation of the LH receptor causes amenorrhea in a 46 XX female. J. Clin. Endocrinol. Metab. 81:1996;3850-3854.
100. Toner J.P., Philput C.B., Jones G.S., Muasher S.J. Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil. Steril. 55:1991;784-791.
101. Vale W., Rivier C., Hsueh A., Campen C., Meunier H., Bicsak T., Vaughan J., Corrigan A., Bardin W., Sawchenko P., Petraglia F., Yu J., Plotsky P., Spiess J., Rivier J. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog. Horm. Res. 44:1988;1-34.
102. van Dessel H.J.H.M., Chandrasekher Y.A., Yap S.O., Le P.P., Hintz R.L., Faessen G.H., Braat D.D., Fauser B.C., Giudice L.C. Serum and ovarian follicle fluid levels of insulin-like growth factors (IGF-I, IGF-II and IGFB-l and -3) during the normal menstrual cycle support a auto/paracrine role for the intraovarian IGF system. J. Clin. Endocrinol. Metab. 81:1996;1224-1231.
103. vanHooff M.H., Alberda A.T., Huisman G.J., Zeilmaker G.H., Leerentveld R.A. Doubling the human menopausal gonadotropin dose in the course of an in vitro fertilization treatment cycle in low responders: a randomized study. Hum. Reprod. 8:1993;369-373.
104. Volpe A., Coukos G., Barreca A. et al. Ovarian response to combined growth hormone-gonadotropin treatment in patients resistant to induction of superovulation. Gynecol. Endocrinol. 3:1989;125-133.
105. Weston A.M., Zelinsky-Wooten M.B., Hutchinson J.S., Stouffer R.L., Wolf D.P. Developmental potential of embryos produced by in-vitro fertilization from gonadotropin-releasing hormone antagonist-treated macaques stimulated with recombinant follicle stimulating hormone alone or in combination with luteinizing hormone. Hum. Reprod. 11:1996;608-613.
106. Wheatcroft N.J., Rogers C.A., Metcalfe R.A., Lenton E.A., Cooke I.D., Weetman A.P. Is subclinical ovarian failure an autoimmune disease? Hum. Reprod. 12:1997;244-249.
107. Widra E.A., Gindoff P.R., Smotrich D.B., Stillman R.J. Achieving multiple-order embryo transfer identifies women over 40 years of age with improved in vitro fertilization outcome. Fertil. Steril. 65:1996;103-108.
108. Wu Tch J., Wang L., Wan Y.J.Y. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil. Steril. 59:1993;54-59.
109. Ying S.Y., Becker A., Ling L., Ueno N., Guillemin R. Inhibin and beta type transforming growth factor (TGFβ) have opposite modulating effects on the follicle-stimulating hormone (FSH) induced aromatase activity of cultured rat granulosa cells. Biochem. Biophys. Res. Commun. 136:1986;969-975.
110. Zeleznik A.J., Schuler H.M., Reichert L.E. Jr. Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology. 109:1981;356-362.